Morning Glory (Ipomoea tricolor)
What Is Morning Glory?
Morning Glory is catalogued in the Materia Medica under the binomial Ipomoea tricolor, a plant of the Convolvulaceae family, native to the American tropics. The material in circulation is seed (toxic) — the fruiting body of the plant. The common name Morning Glory and the botanical name Ipomoea tricolor refer to the same material, and labels may use either — a detail that matters when related species in the same genus are not interchangeable. In the hand it reads as faintly nutty, bitter, green — a practical marker of freshness and correct identification.
The written history of Morning Glory begins with household and practitioner use — recipes, harvesting notes and cautions passed between regions — and only much later with laboratory description of what the seed (toxic) contains. Beyond its practical use it carries cultural associations — tlitliltzin — an Oaxacan divinatory seed used alongside ololiuqui.
Today most searches for Morning Glory come from people reading about weight management, or checking how it sits alongside a medication they already take. The use most often documented in the literature is ergine (LSA) is of pharmacological interest as a natural ergoline, followed by Documented Mazatec divinatory use.
How Does Morning Glory Work?
Morning Glory works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in seed (toxic) rather than by one marker molecule.
Before its chemistry was known, Morning Glory was judged by what it did in the cup: how strongly it brewed, how it tasted, and how little or much was needed. Those notes are why particular preparations survived and others did not.
Published research is limited, leaning on small trials, laboratory work and animal models, and this profile cites 2 sources. Reported findings centre on seeds contain ergine (d-lysergic acid amide) and isoergine at roughly 0.02–0.06% dry weight, produced by a symbiotic Periglandula fungus rather than the plant itself. Where research exists, it examines ergine (LSA) is of pharmacological interest as a natural ergoline, Documented Mazatec divinatory use and widely grown ornamental with genuine horticultural value. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
Morning Glory is studied as a whole preparation because isolating one fraction tends to behave differently from the material it was taken out of — a recurring finding across the plant-chemistry literature.
Because these constituents are processed by the same pathways that handle many medicines, Morning Glory is documented as interacting with triptans, ssris / snris and vasoconstrictors. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Morning Glory can differ substantially; this is why reference entries specify seed (toxic) and, where they exist, standardisation markers.